CD274 and triple-negative breast carcinoma: This second approach is described in Wong and Selbo's 2021 paper titled “Light-controlled elimination of PD-L1+ cells.”24 In this study, Wong and Selbo precisely delivered an immunotoxin to triple negative breast cancer cells in vitro with PD-L1 as a target for cellular uptake.